Holders — by stockHoldings — by fund
5AM Venture Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001799883
$287.9M
disclosed book value
16
positions
11.8%
largest position share
Positions, as of 2026-06-30
top 16 of 16 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MPLTMAPLIGHT THERAPEUTICS INC | 950,011 | $34.0M | 11.8% |
| 2 | TYRATYRA BIOSCIENCES INC | 1.0M | $32.9M | 11.4% |
| 3 | TRDAENTRADA THERAPEUTICS INC | 4.1M | $29.9M | 10.4% |
| 4 | PHARVARIS N V | 797,600 | $27.6M | 9.6% |
| 5 | CAMPCAMP4 THERAPEUTICS CORP | 5.9M | $25.6M | 8.9% |
| 6 | ARTVARTIVA BIOTHERAPEUTICS INC | 2.4M | $22.8M | 7.9% |
| 7 | TECXTECTONIC THERAPEUTIC INC | 606,660 | $20.9M | 7.2% |
| 8 | ZNTLZENTALIS PHARMACEUTICALS INC | 3.9M | $19.1M | 6.7% |
| 9 | CLDXCELLDEX THERAPEUTICS INC NEW | 497,270 | $18.5M | 6.4% |
| 10 | EYPTEYEPOINT INC | 1.1M | $15.0M | 5.2% |
| 11 | BIOHAVEN LTD | 738,972 | $11.0M | 3.8% |
| 12 | SRZNSURROZEN INC | 271,250 | $7.0M | 2.4% |
| 13 | SKYESKYE BIOSCIENCE INC | 9.7M | $6.7M | 2.3% |
| 14 | ALXOALX ONCOLOGY HLDGS INC | 3.1M | $6.3M | 2.2% |
| 15 | TARAPROTARA THERAPEUTICS INC | 1.4M | $5.2M | 1.8% |
| 16 | SLNSILENCE THERAPEUTICS PLC | 476,200 | $5.2M | 1.8% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.